Carolien Zeetsen

143 References R European Monitoring Centre for Drugs and Drug Addiction. (2017). European drug report: trends and developments . Luxembourg, Publications Office of the European Union. Ewert, V., Pelletier, S., Alarcon, R., Nalpas, B., Donnadieu–Rigole, H., Trouillet, R., & Perney, P. (2018). Determination of MoCA cutoff score in patients with alcohol use disorders. Alcoholism: Clinical and Experimental Research, 42 (2), 403–412. https://doi.org/10.1111/acer.13547 Feeney, J., Savva, G.M., O’Regan, C., King–Kallimanis, B., Cronin, H., & Kenny, R.A. (2016). Measurement error, reliability, and minimum detectable change in the Mini–Mental State Examination, Montreal Cognitive Assessment, and Color Trails Test among community living middle–aged and older adults. Journal of Alzheimer’s Disease, 53 (3), 1107–1114. https://doi.org/10.3233/JAD-160248 Fernández–Serrano, M.J., Pérez–García, M., & Verdejo–García, A. (2011). What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance? Neuroscience and Biobehavioral Reviews, 35 (3), 377–406. https://doi.org/10.1016/j.neubiorev.2010.04.008 Folstein, M.F., Folstein, S.E., & McHugh, P.R. (1975). ‘Mini–Mental State’. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12 (3), 189–198. https://doi.org/10.1016/0022-3956( 75)90026-6 Forsberg, L.K., & Goldman, M.S. (1987). Experience–dependent recovery of cognitive deficits in alcoholics: extended transfer of training. Journal of Abnormal Psychology, 96 (4), 345–353. https:// doi.org/10.1037//0021-843x.96.4.345 Freitas, S., Simões, M.R., Alves, L., & Santana, I. (2012). Montreal Cognitive Assessment: influence of sociodemographic and health variables. Archives of Clinical Neuropsychology, 27 (2), 165–175. https://doi.org/10.1093/arclin.acr116 Goldstein, R.Z., Leskovjan, A.C., Hoff, A.L., Hitzemann, R., Bashan, F., Khalsa, S.S., Wang, G.J., Fowler, J.S., & Volkow, N.D. (2004). Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex. Neuropsychologia, 42 (11), 1447–1458. https:// doi.org/10.1016/j.neuropsychologia.2004.04.002 Gonzalez, R., Pacheco–Colón, I., Duperrouzel, J.C., & Hawes, S.W. (2017). Does cannabis use cause declines in neuropsychological functioning? A review of longitudinal studies. Journal of the International Neuropsychological Society, 23 , 893–902. https://doi.org/10.1017/S1355617717000789 de Graaf, A., & Deelman, B.G. (1991). Cognitieve Screening Test: handleiding voor afname en scoring [Cognitive Screening Test: manual for administration and scoring]. Lisse, The Netherlands, Swets en Zeitlinger. Grant, I., Gonzalez, R., Carey, C.L., Natarajan, L., & Wolfson, T. (2003). Non–acute (residual) neurocognitive effects of cannabis use: a meta–analytic study. Journal of the International Neuropsychological Society, 9 (5), 697–689. https://doi.org/10.1017/S1355617703950016 Gruber, S.A., Silveri, M.M., & Yurgelun–Todd, D.A. (2007). Neuropsychological consequences of opiate use. Neuropsychology Review, 17 (3), 299–315. https://doi.org/10.1007/s11065-007-9041-y Grund, J.P., de Bruin, D., & van Gaalen, S. (2018). Going knock – Recurrent comatose GHB intoxication in the Netherlands & Flanders (Belgium). International Journal of Drug Policy, 58 , 137–148. https:// doi.org/10.1016/j.drugpo.2018.06.010